Cargando…
Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway
BACKGROUND: Side population (SP) cells, which have similar features to those of cancer stem cells, show resistance to dexamethasone (Dex) treatment. Thus, new drugs that can be used in combination with Dex to reduce the population of SP cells in multiple myeloma (MM) are required. Diallyl thiosulfin...
Autores principales: | He, Wenfeng, Fu, Yonghui, Zheng, Yongliang, Wang, Xiaoping, Liu, Bin, Zeng, Junquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866463/ https://www.ncbi.nlm.nih.gov/pubmed/33549034 http://dx.doi.org/10.1186/s12885-021-07833-5 |
Ejemplares similares
-
Activation of PI3K/Akt mediates the protective effect of diallyl trisulfide on doxorubicin induced cardiac apoptosis
por: Wen, Su-Ying, et al.
Publicado: (2023) -
Applications and Opportunities in Using Disulfides, Thiosulfinates, and Thiosulfonates as Antibacterials
por: Blume, Lindsay, et al.
Publicado: (2023) -
Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway
por: Yue, Ziqi, et al.
Publicado: (2019) -
A Comparison of the Antibacterial and Antifungal Activities of Thiosulfinate Analogues of Allicin
por: Leontiev, Roman, et al.
Publicado: (2018) -
MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway
por: Lv, Zhongzhe, et al.
Publicado: (2019)